8
total announcements
544172.BO · 15 min delayed
Indegene Ltd
Indegene Ltd has announced its financial results for the quarter ended June 30, 2026, with a net profit of ₹8,682.13 crore and a basic EPS of ₹20.65. The company has filed its quarterly financial results with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Indegene Ltd
Indegene Ltd has made the audio recording of its Q1 FY27 earnings call available on its website and IR portal.
Indegene Ltd
Indegene Ltd has announced its Q1 FY'27 results, showing a 39.7% YoY revenue growth in INR terms and 26.5% in USD. The company has expanded its active client base to 105, improved productivity with revenue per employee rising to $77K, and deepened client relationships with 12 customers generating more than $10 million in annual revenue each.
Indegene Ltd
Indegene Ltd announced its financial results for the quarter ended June 30, 2026, with revenue up 39.7% YoY and PAT up 45.9% QoQ. The company also crossed the 100-milestone in active clients and expanded its customer base in the $10M+ range.
Indegene Ltd
Indegene Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of the proceeds from its IPO.
Indegene Ltd
Indegene Ltd has announced the allotment of shares under its ESOP Scheme 2020, and has also approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's trading window will reopen on August 3, 2026.
Indegene Ltd
Indegene Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and auditor's review report. The company has reported a total revenue of Rs. 413 million and a total loss after tax of Rs. 12 million for the quarter.
Indegene Ltd
Indegene Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the auditor's review report. The company has also approved the allotment under the ESOP Scheme 2020 and reopened the trading window for its designated persons.